kit (Stratagene) according to the manufacturer's instructions. QIAGEN miniprep kit was used for the purification of plasmids according to the manufacturer's instructions. All the mutated plasmids were confirmed by DNA sequence analysis using Eurofins DNA sequencing service. Protein expression was induced by the use of isopropyl-b-D-1-thiogalactopyranoside (IPTG). A prestained protein size marker (6.5-175 kDa) was used to identify protein by 10% SDS-PAGE gel. An amicon YM30 membrane was used for protein concentration. Protein concentration was measured by the Bradford method using bovine serum as the calibration standard. [1] [ (chlorination/diphosphorylation) [2, 3] from commercially available trans,trans-farnesol. 
Introduction of C-terminal hexahistidine tag into DCS. A single nucleotide deletion was required
to bring the His 6 coding sequence of pET21d in frame with the DCS coding sequence. A Quickchange site-directed mutagenesis kit was used to introduce the desired deletion according to the manufacturer's instructions. The primers used for the deletion were as follows:
Forwards: 5'-GAACCAATTGCACTTGAGGATCCGAATTC-3'
Reverse: 5'-GAATTCGGATCCTCAAGTGCAATTGGTTC-3'
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Plasmids were transformed into E. coli XL1 Blue and then purified from overnight cultures (10 mL LB medium containing ampicillin 100 µg/mL) using the miniprep kit as described by the manufacturer. Deletion was confirmed by DNA sequencing.
Production of DCS-His 6
. DCS-His 6 was produced in E. coli BL21(DE3) cells that harboured the cDNA for DCS-His 6 under the control of the T7 promoter. E. coli BL21(DE3) cells were gently defrosted on ice before 1 µL of plasmid (60 ng/µL) was added to the cell suspension. The resulting mixture was stored on ice (30 min), heat shocked in a water bath (42 o C, 30-35 s) and then returned to the ice (2 min). 1 mL of LB medium was added and the solution was incubated for 1 h at 37 o C while shaking.
The cells were harvested by centrifugation (1 min, 3300 g), resuspended in a minimum amount of LB medium and spread on an agar plate containing ampicillin (100 µg/ml). The plate was then incubated overnight at 37 °C.
A single colony from the agar plate harbouring the transformed cells was used to inoculate 100 mL of LB medium containing ampicillin (100 µg/mL) and the culture was allowed to grow at 37 °C with shaking (150 rpm) overnight. 10 mL of the overnight culture was transferred to each of 6 x 500 mL of LB medium containing the same concentration of ampicillin as before. Cells were incubated at 37 °C with shaking (150 rpm), when OD 600 was 0.6, IPTG was added (0.5 mM final concentration) and the cultures were incubated for 24 h with shaking (250 rpm), at 20 °C. Cells were harvested by centrifugation at 5 °C (4200 g, 10 min). The supernatant solution was discarded and the pellets were stored at -20 °C.
Purification of DCS-His 6
. Pellets were allowed to thaw at 5 °C and resuspended in 50 mL of cell lysis buffer (20 mM Tris-Base, 5 mM β-mercaptoethanol (bME), pH 8) and stirred gently for 1 h at 0 °C. Cells were then disrupted by sonication at 5 °C (40 % amplitude for 3 min with 5 sec on/10 s off cycles) and the resulting suspension was centrifuged at 5 °C (17000 g, 30 min). SDS-PAGE analysis showed that protein was in the soluble fraction and the pellets were discarded. The supernatant solution was then loaded onto a 2 cm Amintra NTA (Nitrilotriacetic acid) Ni 2+ column (Expedeon  LTD ) and eluted under gravity controlled drip flow. After 40 minutes the column was washed with 4 column volumes (CV) of binding buffer (Tris-HCl 100 mM, bME 5 mM, NaCl 500 mM, imidazole 5 mM, pH 8). The column was then washed with a gradient of imidazole (from 5 to 300 Mm, 20 CV) in binding buffer. DCS-His 6 eluted in the range 60-100 mM imidazole, column fractions were analysed by SDS-PAGE. The fractions containing pure protein corresponding to a molecular weight of 64000
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(DCS-His 6 ) were pooled, dialysed overnight (10 mM Tris-Base, 5 mM bME, pH 7.5 -MWCO 30000)
and then concentrated to a final volume of ~ 5 mL (AMICON system, YM 30). The solution was aliquoted and stored at 0 °C. The concentration of protein was estimated using the method of Bradford.
[1] 
Site direct mutagenesis
Site directed mutagenesis was carried out using the Quickchange sitedirected mutagenesis kit (Stratagene) according to the manufacturer's instructions. QIAGEN miniprep kit was used for the purification of plasmids according to the manufacturer's instructions.
All the mutated plasmids were confirmed by DNA sequence analysis.
The mutagenic primers for DCS were as follow: 
PCR procedure
Sterile H 2 O (39 μL), Pfu-polymerase buffer (5 μL), dNTPs (1 μL, 10 mM), 2 μL of forward and reverse primers 0.1 mM, 1 μL template DNA 0.01 pmol and 1 μL Pfu-polymerase (2.5 U/μL) were added to a PCR tube and followed PCR protocol ( Table 1 ). The parental DNA was digested with 1 μL DpnI (10 U/μL) for 1 h at 37 °C. The reaction was cooled on ice before transformation into XL1-Blue E. coli S5 cells. Mutations were confirmed by DNA sequence analysis using Eurofins MWG Operon's DNA sequencing service. 
